Pretax income is the income that a company earns before paying income taxes. Vivos Therapeutics's pretax income for the
three
months ended in Mar. 2024 was $-3.76 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-15.64 Mil.
Vivos Therapeutics's pretax margin was -110.06%.
During the past 6 years, Vivos Therapeutics's highest Pretax Margin was -92.28%. The lowest was -222.55%. And the median was -109.29%.
Vivos Therapeutics Pre-Tax Income Historical Data
The historical data trend for Vivos Therapeutics's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Vivos Therapeutics's Pre-Tax Income
For the Medical Devices subindustry, Vivos Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vivos Therapeutics's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vivos Therapeutics's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Vivos Therapeutics's Pre-Tax Income falls into.
Vivos Therapeutics Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Vivos Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-15.64 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vivos Therapeutics (NAS:VVOS) Pre-Tax Income Explanation
Vivos Therapeutics's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as
During the past 6 years, Vivos Therapeutics's highest Pretax Margin was -92.28%. The lowest was -222.55%. And the median was -109.29%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vivos Therapeutics Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Vivos Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Vivos Therapeutics (Vivos Therapeutics) Business Description
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VVOS has been successfully added to your 